Skip to main content
Clinical Trials/NCT04246983
NCT04246983
Completed
Not Applicable

Introducing Point-of-care Ultrasound at the Bedside for Diagnosing Opportunistic Diseases in Patients With HIV

Erasmus Medical Center1 site in 1 country34 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV/AIDS
Sponsor
Erasmus Medical Center
Enrollment
34
Locations
1
Primary Endpoint
Acceptance rate of point-of-care ultrasound by patients
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Rationale: Point-of-care ultrasound (POCUS) is increasingly used by various specialists in the Netherlands, but its role in managing patients with HIV is unclear. In settings endemic for tuberculosis, Fast Assessment with Sonography for HIV/Tuberculosis (FASH) has proven its value to detect extrapulmonary tuberculosis in patients with HIV. However, there is no data to support POCUS for patients with HIV in resource affluent settings.

Objective: The investigators aim to determine the feasibility and diagnostic value of POCUS in detecting opportunistic disease in HIV patients with advanced disease stages in the Netherlands.

Study design: The investigators will perform a prospective observational pilot study.

Study population: The investigators will include new adult patients with HIV presenting with a cluster of differentiation 4 (CD4) T-cell count below 350 cells/mm3, and all adult HIV patients requiring admission to hospital. Intervention (if applicable): The investigators will perform a focused ultrasound examination including FASH, and ultrasound of the lung, liver and kidneys. In case of positive findings additional examinations will be undertaken to determine the underlying pathology and/or treatment started as indicated. In case of negative findings, patients will be followed for 12 months to observe for (possibly missed) opportunistic infections.

Main study parameters/endpoints: Our primary outcomes include acceptability of POCUS by patients, interobserver variation in interpretation of POCUS images, and number of diagnosed AIDS and non-AIDS related problems. Secondary outcomes include sensitivity and specificity, negative predictive value and positive predictive value of our POCUS protocol. In addition, incidence rates of opportunistic infections will be compared to a historical matched control group.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The ultrasound examination is painless and without risk to the participants. It will take approximately 30 minutes and will be combined with routine visits to the hospital. Benefits include potential earlier detection of opportunistic disease, while adverse effects may arise from false positive findings requiring further examinations which may cause stress or anxiety. The rate of false positive findings in POCUS has not been formally investigated, but appears low. The effect of POCUS in advanced HIV/AIDS can only be studied in HIV patients.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
December 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mischa Huson

Principal Investigator

Erasmus Medical Center

Eligibility Criteria

Inclusion Criteria

  • new patients with HIV presenting with a CD4 T-cell count below 350 cells/mm3
  • patients with HIV who are admitted to hospital

Exclusion Criteria

  • absence of informed consent

Outcomes

Primary Outcomes

Acceptance rate of point-of-care ultrasound by patients

Time Frame: 1 day

interobserver variation in interpretation of ultrasound images

Time Frame: 1 day

Number of diagnosed AIDS and non-AIDS related problems

Time Frame: 1 year

Secondary Outcomes

  • Sensitivity and specificity, negative predictive value and positive predictive value of our ultrasound protocol to diagnose opportunistic disease.(1 year)
  • Number of diagnosed AIDS and non-AIDS related problems compared to a historic control group(1 year)

Study Sites (1)

Loading locations...

Similar Trials